Close X

In order to view this PDF document, you must be a registered member of the AsthmaKidCare™ program. To sign up now, please visit the AsthmaKidCare™ registration page.

If you are already a member, simply log in below.

E-mail:
Password:
Sign In

Close X

By listing your child’s date of birth, AsthmaKidCare™ is able to provide you and your child with age-specific information, tips, and resources.

Error

The page you are looking for does not exist.

We are sorry for the inconvenience.

If you would like additional information regarding AstraZeneca's products, please contact the Information Center at AstraZeneca in the U.S. at 1-800-236-9933, Monday through Friday 8am - 6pm ET, excluding holidays.

Back to home

Enlarge Text:

Print:

Approved Use

PULMICORT RESPULES is developed and approved specifically for children 12 months to 8 years of age, to help prevent asthma symptoms that could lead to an attack.

PULMICORT RESPULES, an inhaled corticosteroid, is not a quick-relief medication and should NOT be used to treat an acute asthma attack

Important Safety Information

Inhaled corticosteroids may cause a reduction in growth rate. The long-term effect on final adult height is unknown
If switching to PULMICORT RESPULES from an oral (syrup or pill) corticosteroid, follow the doctor's instructions to help avoid health risks
Tell the doctor if your child is exposed to chicken pox or measles
Side Effects: In studies, side effects included respiratory infection, runny nose, earache, and coughing

Talk to your doctor about PULMICORT RESPULES.

Read the full Prescribing Information (PDF – 242KB)

Read Important Product Information for Patients.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088.

flag This product information is intended for US consumers only.

Site Map | Contact Us | US Corporate Site